wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38078053-46A4C5E5-28D4-4B6A-A417-7D94994EDB47
Q38078053-46A4C5E5-28D4-4B6A-A417-7D94994EDB47
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38078053-46A4C5E5-28D4-4B6A-A417-7D94994EDB47
Endocannabinoid system modulator use in everyday clinical practice in the UK and Spain.
P2860
Q38078053-46A4C5E5-28D4-4B6A-A417-7D94994EDB47
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38078053-46A4C5E5-28D4-4B6A-A417-7D94994EDB47
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
d5ea627e1bc9701aa7d44fbe194ed8697349b7c2
P2860
A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols* (Sativex(®) ), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis.